{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:41Z","timestamp":1786993721899,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.lfs.2022.120335","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T20:16:22Z","timestamp":1642450582000},"page":"120335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes"],"prefix":"10.1016","volume":"293","author":[{"given":"Jos\u00e9 \u00c1ngel","family":"Garc\u00eda-Pedraza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alarc\u00f3n-Torrecillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rodr\u00edguez-Barbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Garc\u00eda-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120335_bb0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the World Health Surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.120335_bb0010","article-title":"Diabetes increases the risk of depression: a systematic review, meta-analysis and estimates of population attributable fractions based on prospective studies","volume":"14","author":"Chireh","year":"2019","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.lfs.2022.120335_bb0015","article-title":"Psychiatric illness, emotional distress, glycemic control and chronic complications in type 1 diabetes subjects","volume":"2359","author":"Fritzen","year":"2021","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.120335_bb0020","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.2337\/db10-0862","article-title":"Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes","volume":"59","author":"Secrest","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2022.120335_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11892-021-01400-9","article-title":"Cardiovascular risk management in type 1 diabetes","volume":"21","author":"Teoh","year":"2021","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.lfs.2022.120335_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.617459","article-title":"Autonomic modulation for cardiovascular disease","volume":"11","author":"Hadaya","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2022.120335_bb0035","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ajh.2010.154","article-title":"Sympathetic neural activity in hypertension and related diseases","volume":"23","author":"Grassi","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2022.120335_bb0040","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/eurheartj\/eht462","article-title":"Depression and cardiovascular disease: a clinical review","volume":"35","author":"Hare","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2022.120335_bb0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.bjp.0701714","article-title":"Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat","volume":"123","author":"Mor\u00e1n","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vph.2015.05.003","article-title":"5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats","volume":"72","author":"Garc\u00eda-Pedraza","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0055","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/1440-1681.12841","article-title":"5-HT modulates the rat mesenteric vasopressor outflow by 5-HT(1D) sympatholytic receptors","volume":"44","author":"Garc\u00eda-Pedraza","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2022.120335_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2013.05.045","article-title":"Peripheral 5-HT1D and 5-HT7 serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats","volume":"714","author":"Garc\u00eda-Pedraza","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bjp.0706216","volume":"145","author":"Garc\u00eda","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2010.06.013","article-title":"Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats","volume":"643","author":"Mor\u00e1n","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1176\/appi.ajp.2015.15030331","article-title":"Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder","volume":"173","author":"Jakubovski","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.lfs.2022.120335_bb0080","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/HJH.0b013e32829baae7","article-title":"Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?","volume":"25","author":"Barton","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2022.120335_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1291\/hypres.30.285","article-title":"Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk","volume":"30","author":"Dawood","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2022.120335_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2017.02.029","article-title":"Chronic treatment with fluoxetine modulates vascular adrenergic responses by inhibition of pre- and post-synaptic mechanisms","volume":"800","author":"Pereira","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jphs.2021.05.008","article-title":"Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment","volume":"147","author":"Garc\u00eda-Pedraza","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2022.120335_bb0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/PSY.0000000000000707","article-title":"The association between selective serotonin reuptake inhibitors and glycemia: a systematic review and meta-analysis of randomized controlled trials","volume":"81","author":"Tharmaraja","year":"2019","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.lfs.2022.120335_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamapsychiatry.2020.2762","article-title":"Association of selective serotonin reuptake inhibitors with the risk of type 2 diabetes in children and adolescents","volume":"78","author":"Sun","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.lfs.2022.120335_bb0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1139\/cjpp-2018-0390","article-title":"Fluoxetine oral treatment discloses 5-HT(1D) receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat","volume":"97","author":"L\u00f3pez","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0115","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/0253717620971200","article-title":"Managing depression in diabetes mellitus: a multicentric randomized controlled trial comparing effectiveness of fluoxetine and mindfulness in primary care: protocol for DIAbetes Mellitus ANd Depression (DIAMAND) study","volume":"42","author":"Chandra","year":"2020","journal-title":"IndianJ. Psychol. Med."},{"key":"10.1016\/j.lfs.2022.120335_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jagp.2013.01.018","article-title":"The association of selective serotonin reuptake inhibitors use and stroke in geriatric population","volume":"21","author":"Hung","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.lfs.2022.120335_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.373","article-title":"Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence","volume":"5","author":"Siepmann","year":"2015","journal-title":"Brain Behav."},{"key":"10.1016\/j.lfs.2022.120335_bb0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpsychires.2013.11.008","article-title":"Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression","volume":"50","author":"Able","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.lfs.2022.120335_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1474-8673.2010.00458.x","article-title":"Effects of repeated maprotiline and fluoxetine treatment on gene expression of catecholamine synthesizing enzymes in adrenal medulla of unstressed and stressed rats","volume":"30","author":"Spasojevic","year":"2010","journal-title":"Auton. Autacoid. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021551","article-title":"Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials","volume":"6","author":"Ye","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.120335_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111848","article-title":"Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis","volume":"141","author":"Chiu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2022.120335_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.12998\/wjcc.v1.i5.169","article-title":"Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes","volume":"1","author":"Biagetti","year":"2013","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.lfs.2022.120335_bb0155","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s13105-014-0361-0","article-title":"Fluoxetine ameliorates imbalance of redox homeostasis and inflammation in an acute kidney injury model","volume":"70","author":"Aksu","year":"2014","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2022.120335_bb0160","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1590\/1414-431X20143698","article-title":"Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity","volume":"47","author":"Tiradentes","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.lfs.2022.120335_bb0165","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","article-title":"Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype","volume":"268","author":"Shen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120335_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.conb.2009.06.005","article-title":"Presynaptic signal transduction pathways that modulate synaptic transmission","volume":"19","author":"de Jong","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.lfs.2022.120335_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WNR.0000000000000930","article-title":"Ritanserin, a serotonin-2 receptor antagonist, inhibits functional recovery after cerebral infarction","volume":"29","author":"Mizutani","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.lfs.2022.120335_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/cne.20082","article-title":"The 5-HT2A receptor is widely distributed in the rat spinal cord and mainly localized at the plasma membrane of postsynaptic neurons","volume":"472","author":"Doly","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.lfs.2022.120335_bb0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1472-8206.2000.tb00426.x","article-title":"Fluoxetine-induced pressor response in freely moving rats: a role for vasopressin and sympathetic tone","volume":"14","author":"Lazartigues","year":"2000","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120335_bb0190","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2337\/db08-1000","article-title":"Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes","volume":"57","author":"Briscoe","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2022.120335_bb0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000108381","article-title":"Depressive symptoms are related to decreased low-frequency heart rate variability in older adults with decompensated heart failure","volume":"55","author":"Guinjoan","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.lfs.2022.120335_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2017.03.007","article-title":"The heartbreak of depression: 'Psycho-cardiac' coupling in myocardial infarction","volume":"106","author":"Headrick","year":"2017","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:52:43Z","timestamp":1758401563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"alternative-id":["S0024320522000352"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120335","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120335"}}